We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$78.7M
Cap. Flow
-$22.3M
Cap. Flow %
-1.23%
Top 10 Hldgs %
34.83%
Holding
244
New
11
Increased
33
Reduced
78
Closed
17

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$34.1M
2
NFLX icon
Netflix
NFLX
+$17.9M
3
ASML icon
ASML
ASML
+$17.6M
4
SYK icon
Stryker
SYK
+$17.3M
5
OABI icon
OmniAb
OABI
+$12.6M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$30.9M
2
GPN icon
Global Payments
GPN
+$29.9M
3
LGND icon
Ligand Pharmaceuticals
LGND
+$27.1M
4
SBNY
Signature Bank
SBNY
+$20.7M
5
TNDM icon
Tandem Diabetes Care
TNDM
+$6.87M

Sector Composition

Rank Sector Weight
1 Healthcare 23.73%
2 Technology 23.69%
3 Financials 16.04%
4 Communication Services 9.8%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
201
GSK
GSK
$104B
$249K 0.01%
7,100
– –
CTVA icon
202
Corteva
CTVA
$52.6B
$248K 0.01%
4,221
– –
BALL icon
203
Ball Corp
BALL
$17.3B
$245K 0.01%
4,800
– –
MLM icon
204
Martin Marietta Materials
MLM
$31.5B
$245K 0.01%
724
-124
-15% -$42.3K
NVS icon
205
Novartis
NVS
$297B
$240K 0.01%
2,640
-750
-22% -$63.2K
TTWO icon
206
Take-Two Interactive
TTWO
$45.4B
$239K 0.01%
2,297
-671
-23% -$72.7K
K
207
DELISTED
Kellanova
K
$237K 0.01%
+3,546
New +$241K
EXAS
208
DELISTED
Exact Sciences
EXAS
$220K 0.01%
+4,451
New +$182K
EOG icon
209
EOG Resources
EOG
$79.2B
$215K 0.01%
+1,660
New +$221K
BEN icon
210
Franklin Resources
BEN
$17.6B
$211K 0.01%
+8,004
New +$199K
KHC icon
211
Kraft Heinz
KHC
$30.7B
$211K 0.01%
5,186
-157,978
-97% -$6M
PRAA icon
212
PRA Group
PRAA
$663M
$210K 0.01%
6,220
– –
NUE icon
213
Nucor
NUE
$58.6B
$209K 0.01%
+1,584
New +$215K
DD icon
214
DuPont de Nemours
DD
$18.5B
$206K 0.01%
+2,395
New +$191K
PPL
215
PPL Corp
PPL
$26.5B
$201K 0.01%
+6,895
New +$190K
TEAM icon
216
Atlassian
TEAM
$25.6B
$201K 0.01%
1,565
-10
-0.6% -$1.59K
MNTS icon
217
Momentus
MNTS
$76.3M
$185K 0.01%
19
– –
PLTR icon
218
Palantir
PLTR
$295B
$157K 0.01%
24,525
-109,516
-82% -$830K
PSLV icon
219
Sprott Physical Silver Trust
PSLV
$12B
$132K 0.01%
16,000
– –
CIM
220
Chimera Investment
CIM
$1.04B
$118K 0.01%
7,167
– –
DNP icon
221
DNP Select Income Fund
DNP
$4.05B
$115K 0.01%
10,215
– –
HWELU
222
DELISTED
Healthwell Acquisition Corp. I Unit
HWELU
$98.9K 0.01%
10,000
– –
GRPN icon
223
Groupon
GRPN
$1.05B
$85.8K ﹤0.01%
+10,000
New +$77.4K
CS
224
DELISTED
Credit Suisse Group
CS
$76K ﹤0.01%
+25,000
New +$97.3K
LYG icon
225
Lloyds Banking Group
LYG
$89.5B
$66K ﹤0.01%
30,000
– –
6 7 8
9
10

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Chicago Capital held 244 positions worth $1.81B, up 4.6% from $1.73B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Chicago Capital's Q4 2022 filing shows 11 new, 33 increased, 78 reduced and 17 closed positions. Its largest new stake was OmniAb: 2,400,717 shares worth $8.64M. The largest sale was Abiomed Inc, an estimated $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Chicago Capital's largest Q4 2022 buy was OmniAb: 2,400,717 shares worth $8.64M.
  • Chicago Capital added most to Intuit in Q4 2022, an estimated $34.1M increase.
  • Chicago Capital's biggest Q4 2022 reduction was Global Payments, cutting an estimated $29.9M.
  • Chicago Capital fully exited Abiomed Inc in Q4 2022, selling an estimated $30.9M.
  • Chicago Capital's ten largest holdings make up 35% of its $1.81B portfolio in Q4 2022.
  • Chicago Capital opened 11 new positions and closed 17 in Q4 2022.
  • Chicago Capital's portfolio value rose 4.6% quarter-over-quarter to $1.81B.

Based on Chicago Capital's 13F filing for Q4 2022, filed 20 Jan 2023.